Hyperliquid Strategies (NASDAQ:PURR) Stock Rating Upgraded by Cantor Fitzgerald

Hyperliquid Strategies (NASDAQ:PURR) was upgraded by equities researchers at Cantor Fitzgerald to a “strong-buy” rating in a report released on Thursday,Zacks.com reports.

A number of other equities research analysts have also weighed in on the company. Weiss Ratings started coverage on Hyperliquid Strategies in a research note on Monday, March 2nd. They set a “sell (e)” rating on the stock. Wall Street Zen upgraded Hyperliquid Strategies to a “hold” rating in a research note on Saturday, February 21st. Finally, Chardan Capital boosted their price target on Hyperliquid Strategies from $8.15 to $8.45 and gave the stock a “buy” rating in a research note on Thursday, February 12th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, Hyperliquid Strategies currently has a consensus rating of “Moderate Buy” and an average price target of $7.23.

Hyperliquid Strategies Price Performance

Shares of Hyperliquid Strategies stock opened at $6.01 on Thursday. The company has a market capitalization of $745.06 million, a P/E ratio of -0.65 and a beta of 1.38. The business has a 50-day moving average price of $4.93. Hyperliquid Strategies has a one year low of $3.01 and a one year high of $6.63.

Hyperliquid Strategies (NASDAQ:PURR) last issued its quarterly earnings results on Wednesday, February 11th. The company reported ($7.43) earnings per share for the quarter. The firm had revenue of $0.50 million during the quarter.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Boothbay Fund Management LLC acquired a new position in Hyperliquid Strategies in the 4th quarter valued at $40,000. XTX Topco Ltd purchased a new stake in Hyperliquid Strategies in the 4th quarter valued at $48,000. Squarepoint Ops LLC purchased a new stake in Hyperliquid Strategies in the 4th quarter valued at $73,000. Millennium Management LLC purchased a new stake in Hyperliquid Strategies in the 4th quarter valued at $87,000. Finally, Ikarian Capital LLC purchased a new stake in Hyperliquid Strategies in the 4th quarter valued at $107,000. 9.45% of the stock is owned by institutional investors and hedge funds.

About Hyperliquid Strategies

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.